The Past and Future of Trabeculectomy

New scarring prophylaxis could facilitate greater use of the most effective glaucoma procedure.

By Keith Barton, MD

Cost-benefit Analysis of Virtual Reality Visual Fields as Adjunct to Standard Automated Perimetry

Headsets can be both cost effective and convenient.

By Sean J. McCafferty, MD

New Supraciliary Interventions for Glaucoma

Increased attention is being given to this anatomic space for glaucoma procedures.

By Ticiana De Francesco, MD, Sean Ianchulev, MD, MPH

Floppy Eyelid Syndrome and Obstructive Sleep Apnea in Glaucoma

Screen for a common glaucoma risk factor with this one weird trick.

By Matthew J.A. Brink, MD, Jack Martinyan, BS

Interventional Glaucoma Q&A With Sahar Bedrood, MD

By Sahar Bedrood, MD, PhD

From the Editor: Local Coverage Determination Debacle Part Two

By Nathan Radcliffe, MD

Trials in Focus: The COAST Trial of Selective Laser Trabeculoplasty

Researchers are looking at the best way to perform primary and repeat SLT.

By Tony Realini, MD, MPH

Coding: Stents and Visual Field Testing

Reimbursement for glaucoma surgery with an aqueous drainage device often depends on visual field testing.

By Kevin J. Corcoran, COE, FNAO

Patients Are Asking: Why Is My Glaucoma Getting Worse When My Eye Pressures Are so Good?

Help patients optimize systemic factors in normal-tension glaucoma.

By Victoria M. Addis, MD

Product Spotlight: A New Lens Makes Two-handed MIGS Possible

Gonio Ready expands options for minimally invasive surgery.

By Karen Appold, contributing writer

ViaLase Completes Enrollment for Pivotal Trial of Laser for POAG

By Jennifer Ford, content director

Miniject Safe and Effective at 3 Years

By Conni Koury, contributing editor

Cilioscleral Device Significantly and Safely Reduced IOP at 1 Year

By Conni Koury, contributing editor

Fixed High-energy SLT Superior to Standard Titrated Protocol for IOP Lowering

By Conni Koury, contributing editor

Netarsudil Plus Latanoprost Noninferior to Bimatoprost-timolol Combo

By Conni Koury, contributing editor

Data From Large-scale Investigation Demonstrate MIGS Efficacy

By Conni Koury, contributing editor

Intravitreal Implant Moves to Phase 2a

By Conni Koury, contributing editor

Generic Brimonidine 0.1% Launched

By Conni Koury, contributing editor

First In-human Study of Titratable Aqueous Shunt Therapy Has Begun

By Conni Koury, contributing editor

Telemedicine Screenings Effective, Scalable for At-risk Patients

By Conni Koury, contributing editor

FDA Clears Belkin Eagle Device for SLT

By Conni Koury, contributing editor

Glaukos iDose TR Gets FDA Approval

By Conni Koury, contributing editor

Restrictive LCDs for MIGS Will Not Go Into Effect

Five MACs retired their proposed LCDs for MIGS.